Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 139
9
Diseases
246
Unique genes
0.065
Avg. similarity score
Colitis
Most-connected disease (5 links)
Disease
Searched: Status epilepticus
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Status epilepticus
Colitis
Brain ischemia
Brain injuries
Necrosis
thrombocytopenia 6
Developmental delay with overweight and facial dysmorphism
inflammatory skin and bowel disease, neonatal, 1
macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Colitis | 5 | 5 | 33 |
| Brain ischemia | 4 | 4 | 70 |
| Status epilepticus | 4 | 4 | 70 |
| Brain injuries | 3 | 3 | 80 |
| Necrosis | 3 | 3 | 55 |
| thrombocytopenia 6 | 2 | 2 | 1 |
| Developmental delay with overweight and facial dysmorphism | 1 | 1 | 1 |
| inflammatory skin and bowel disease, neonatal, 1 | 1 | 1 | 1 |
| macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| NOS2 | 5 / 9 | Brain injuries, Brain ischemia, Colitis, Necrosis and 1 more |
| TNF | 5 / 9 | Brain injuries, Brain ischemia, Colitis, Necrosis and 1 more |
| IL1B | 4 / 9 | Brain injuries, Brain ischemia, Colitis, Necrosis |
| IL1RN | 4 / 9 | Brain injuries, Brain ischemia, Necrosis, Status epilepticus |
| IL6 | 4 / 9 | Brain injuries, Brain ischemia, Colitis, Necrosis |
| PTGS2 | 4 / 9 | Brain injuries, Brain ischemia, Colitis, Status epilepticus |
| BDNF | 3 / 9 | Brain injuries, Brain ischemia, Status epilepticus |
| CAT | 3 / 9 | Brain ischemia, Necrosis, Status epilepticus |
| CCL2 | 3 / 9 | Brain injuries, Brain ischemia, Status epilepticus |
| IL17A | 3 / 9 | Brain ischemia, Colitis, Necrosis |
| JUN | 3 / 9 | Brain injuries, Brain ischemia, Status epilepticus |
| MPO | 3 / 9 | Brain injuries, Brain ischemia, Colitis |
| RELA | 3 / 9 | Brain injuries, Brain ischemia, Colitis |
| SOD2 | 3 / 9 | Brain injuries, Brain ischemia, Necrosis |
| SRC | 3 / 9 | Colitis, Status epilepticus, thrombocytopenia 6 |
| ADAM17 | 2 / 9 | Colitis, inflammatory skin and bowel disease, neonatal, 1 |
| AHR | 2 / 9 | Colitis, Necrosis |
| ALB | 2 / 9 | Brain injuries, Brain ischemia |
| ASIC1 | 2 / 9 | Brain injuries, Brain ischemia |
| BECN1 | 2 / 9 | Brain injuries, Status epilepticus |
| CASP3 | 2 / 9 | Brain ischemia, Status epilepticus |
| CCL3 | 2 / 9 | Brain ischemia, Status epilepticus |
| CDC42 | 2 / 9 | macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome, Necrosis |
| CEBPB | 2 / 9 | Brain injuries, Brain ischemia |
| CSF3 | 2 / 9 | Brain injuries, Brain ischemia |
| CXCL10 | 2 / 9 | Brain injuries, Brain ischemia |
| DMD | 2 / 9 | Necrosis, Status epilepticus |
| EPO | 2 / 9 | Brain injuries, Status epilepticus |
| FOS | 2 / 9 | Brain injuries, Status epilepticus |
| HMOX1 | 2 / 9 | Colitis, Status epilepticus |
| ICAM1 | 2 / 9 | Brain injuries, Brain ischemia |
| IFNG | 2 / 9 | Colitis, Necrosis |
| IGF1 | 2 / 9 | Brain ischemia, Colitis |
| IL10 | 2 / 9 | Brain injuries, Colitis |
| IL1A | 2 / 9 | Brain injuries, Brain ischemia |
| MMP9 | 2 / 9 | Brain injuries, Brain ischemia |
| MTHFR | 2 / 9 | Brain ischemia, Necrosis |
| PARP1 | 2 / 9 | Brain injuries, Brain ischemia |
| SOD1 | 2 / 9 | Brain ischemia, Necrosis |
| SRRM2 | 2 / 9 | Developmental delay with overweight and facial dysmorphism, Status epilepticus |
| TNFRSF1A | 2 / 9 | Brain injuries, Brain ischemia |
| UCP2 | 2 / 9 | Brain injuries, Brain ischemia |
| VEGFA | 2 / 9 | Brain injuries, Status epilepticus |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Lipid and atherosclerosis | KEGG | 45 / 216 | 10.2× | 5.96e-33 | 1.84e-29 ✓ sig. |
| Cytokine-cytokine receptor interaction | KEGG | 49 / 298 | 8.0× | 8.59e-31 | 2.38e-27 ✓ sig. |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 29 / 108 | 13.1× | 8.23e-25 | 1.25e-21 ✓ sig. |
| IL-17 signaling pathway | KEGG | 26 / 94 | 13.5× | 1.05e-22 | 1.18e-19 ✓ sig. |
| TNF signaling pathway | KEGG | 28 / 119 | 11.5× | 2.94e-22 | 3.07e-19 ✓ sig. |
| Interleukin-10 signaling | Reactome | 20 / 47 | 20.8× | 4.65e-22 | 4.69e-19 ✓ sig. |
| Kaposi sarcoma-associated herpesvirus infection | KEGG | 33 / 196 | 8.2× | 3.51e-21 | 2.99e-18 ✓ sig. |
| Toxoplasmosis | KEGG | 26 / 112 | 11.3× | 1.42e-20 | 1.11e-17 ✓ sig. |
| Viral protein interaction with cytokine and cytokine receptor | KEGG | 24 / 100 | 11.7× | 1.94e-19 | 1.30e-16 ✓ sig. |
| Apoptosis | KEGG | 27 / 137 | 9.6× | 2.44e-19 | 1.61e-16 ✓ sig. |
| Measles | KEGG | 27 / 139 | 9.5× | 3.63e-19 | 2.32e-16 ✓ sig. |
| Tuberculosis | KEGG | 30 / 181 | 8.1× | 3.97e-19 | 2.51e-16 ✓ sig. |
| Chagas disease | KEGG | 24 / 103 | 11.4× | 4.12e-19 | 2.60e-16 ✓ sig. |
| MAPK signaling pathway | KEGG | 37 / 299 | 6.0× | 6.17e-19 | 3.81e-16 ✓ sig. |
| Pathways in cancer | KEGG | 48 / 533 | 4.4× | 1.54e-18 | 9.26e-16 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| inflammatory response | GO:0006954 | 51 / 467 | 8.3× | 3.36e-32 | 2.20e-28 ✓ sig. |
| immune response | GO:0006955 | 47 / 543 | 6.6× | 3.44e-25 | 1.19e-21 ✓ sig. |
| negative regulation of apoptotic process | GO:0043066 | 46 / 524 | 6.7× | 6.50e-25 | 2.18e-21 ✓ sig. |
| response to lipopolysaccharide | GO:0032496 | 29 / 161 | 13.7× | 9.14e-25 | 2.93e-21 ✓ sig. |
| cellular response to lipopolysaccharide | GO:0071222 | 29 / 187 | 11.8× | 7.75e-23 | 1.87e-19 ✓ sig. |
| positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | GO:0051897 | 30 / 217 | 10.5× | 4.27e-22 | 9.17e-19 ✓ sig. |
| positive regulation of gene expression | GO:0010628 | 42 / 504 | 6.3× | 6.81e-22 | 1.43e-18 ✓ sig. |
| positive regulation of chemokine production | GO:0032722 | 17 / 49 | 26.4× | 2.74e-20 | 4.61e-17 ✓ sig. |
| positive regulation of MAPK cascade | GO:0043410 | 28 / 224 | 9.5× | 1.77e-19 | 2.61e-16 ✓ sig. |
| response to xenobiotic stimulus | GO:0009410 | 29 / 248 | 8.9× | 2.50e-19 | 3.59e-16 ✓ sig. |
| positive regulation of inflammatory response | GO:0050729 | 22 / 122 | 13.7× | 4.82e-19 | 6.49e-16 ✓ sig. |
| apoptotic process | GO:0006915 | 46 / 747 | 4.7× | 1.30e-18 | 1.64e-15 ✓ sig. |
| positive regulation of ERK1 and ERK2 cascade | GO:0070374 | 26 / 201 | 9.8× | 1.55e-18 | 1.92e-15 ✓ sig. |
| response to hypoxia | GO:0001666 | 23 / 176 | 9.9× | 1.28e-16 | 1.19e-13 ✓ sig. |
| positive regulation of interleukin-8 production | GO:0032757 | 16 / 65 | 18.7× | 1.82e-16 | 1.65e-13 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Brain injuries | Brain ischemia | 0.180 | 23 | 1.33e-36 | 5.12e-35 ✓ sig. |
| Brain ischemia | Colitis | 0.095 | 9 | 1.72e-14 | 2.37e-13 ✓ sig. |
| Brain ischemia | Necrosis | 0.086 | 10 | 4.80e-14 | 6.37e-13 ✓ sig. |
| Brain injuries | Status epilepticus | 0.079 | 11 | 6.17e-14 | 8.12e-13 ✓ sig. |
| Brain ischemia | Status epilepticus | 0.076 | 10 | 6.18e-13 | 7.57e-12 ✓ sig. |
| Brain injuries | Colitis | 0.075 | 8 | 4.64e-12 | 5.23e-11 ✓ sig. |
| Colitis | Necrosis | 0.085 | 7 | 1.99e-11 | 2.12e-10 ✓ sig. |
| Colitis | inflammatory skin and bowel disease, neonatal, 1 | 0.029 | 1 | 2.14e-3 | 3.04e-3 ✓ sig. |
| Colitis | thrombocytopenia 6 | 0.029 | 1 | 2.14e-3 | 3.04e-3 ✓ sig. |
| macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome | Necrosis | 0.018 | 1 | 3.57e-3 | 4.59e-3 ✓ sig. |
| Developmental delay with overweight and facial dysmorphism | Status epilepticus | 0.014 | 1 | 4.55e-3 | 5.67e-3 ✓ sig. |
| Status epilepticus | thrombocytopenia 6 | 0.014 | 1 | 4.55e-3 | 5.67e-3 ✓ sig. |